Ms. Sahney has over 25 years of executive leadership experience in the successful development and commercialization of innovation driven and customer-centric products. Currently, she serves as the global President of the Pelvic Health Operating Unit at Medtronic, which includes the InterStim® portfolio. She is an active member of the MedTech community and has served as a mentor, investor, and board member for multiple start-ups.
Previously, she was the President and CEO of Hyalex Orthopaedics, an award-winning venture backed synthetic cartilage company. Earlier in her career she served as the SVP and General Manager of the ENT and Gynecology divisions at Smith + Nephew, leading two high-growth businesses with global P&L responsibility. She also co-founded and led Myomo Inc. a neuro-robotics company that is now public on the NYSE. Sahney graduated from the MIT Leaders for Global Operations (LGO) program with an MBA from the MIT Sloan School of Management and a MS in mechanical engineering. Additionally, she holds an MS from Stanford University and a BSE from the University of Michigan. When she is not working, she enjoys skiing, biking, hiking, and doing her best to keep up with her husband and three children.
Explore how teams can build AI/ML software with the same scale, safety, and process control seen in medical device and pharmaceutical factories. Experts will discuss the spectrum of AI/ML applications in MedTech, the validation and governance challenges of AI-enhanced software, and the impact of the Predetermined Change Control Plan (PCCP) on innovation. Panelists will also share their thoughts on how open-source software, continuous integration and deployment (CI/CD), and automation are crucial for building next generation software factories.